版本:
中国

BRIEF-U.S. FDA grants accelerated approval to Avelumab for Urothelial Carcinoma

May 9 U.S. FDA:

* U.S. Food and Drug Administration grants accelerated approval to avelumab for urothelial carcinoma Source text (bit.ly/2pgHp8q) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐